Form 8-K - Current report:
SEC Accession No. 0001193125-25-161486
Filing Date
2025-07-21
Accepted
2025-07-21 07:05:13
Documents
12
Period of Report
2025-07-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d82581d8k.htm   iXBRL 8-K 33258
  Complete submission text file 0001193125-25-161486.txt   153572

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA thrd-20250716.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE thrd-20250716_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thrd-20250716_pre.xml EX-101.PRE 11717
14 EXTRACTED XBRL INSTANCE DOCUMENT d82581d8k_htm.xml XML 3778
Mailing Address 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111
Business Address 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111 2097272457
Third Harmonic Bio, Inc. (Filer) CIK: 0001923840 (see all company filings)

EIN.: 834553503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41498 | Film No.: 251135688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)